Search Results - "Rosema, Bram‐Sieben"

Personal preferences for treatment and care during and after a First Episode Psychosis: A qualitative study by Heijden‐Hobus, Inge M. W., Rosema, Bram‐Sieben, Vorstman, Jacob A. S., Kas, Martien J. H., Franke, Sigrid K., Boonstra, Nynke, Sommer, Iris E. C.

“…Aim A first episode of psychosis (FEP) is a stressful, often life‐changing experience. Scarce information is available about personal preferences regarding…”
Get full text

Personal recovery in first-episode psychosis: Beyond clinical and functional recovery by Maas, Isolde L., Bohlken, Marc M., Gangadin, Shiral S., Rosema, Bram-Sieben, Veling, Wim, Boonstra, Nynke, de Haan, Lieuwe, Begemann, Marieke J.H., Koops, Sanne

“…The concept of personal recovery after psychotic illness focuses more on patients' social and existential needs compared to traditional outcome measures…”
Get full text

Medication strategies in first episode psychosis patients: A survey among psychiatrists by Kikkert, Martijn J., Veling, Wim, Haan, Lieuwe, Begemann, Marieke J. H., Koning, Mariken, Sommer, Iris, Haan, Lieuwe, Veling, Wim, Os, Jim, Smit, Filip, Begemann, Marieke, Schuite‐Koops, Sanne, Marcelis, Machteld, Kikkert, Martijn, Beveren, Nico, Boonstra, Nynke, Rosema, Bram‐Sieben, Bakker, P. Roberto, Gülöksüz, Sinan, Lokkerbol, Joran, Brand, Bodyl, Gangadin, Shiral, Geraets, Chris, van't Hag, Erna, Oomen, Priscilla, Voppel, Alban, Amelsvoort, Therese, Bak, Maarten, Been, Agaath, Bosch, Marinte, Brink, Truus, Faber, Gunnar, Grootens, Koen, Jonge, Martin, Knegtering, Henderikus, Kurkamp, Jörg, Mahabir, Amrita, Pijnenborg, Gerdina Hendrika Maria, Staring, Tonnie, Vaes, Wiek, Veen, Natalie, Veerman, Selene, Wiersma, Sybren, Sommer, Iris E.

“…Aim There is an ongoing debate regarding the optimal timing of discontinuation of antipsychotic drugs for patients with first episode psychosis. Although most…”
Get full text

Selection of effective antisense oligodeoxynucleotides with a green fluorescent protein-based assay. Discovery of selective and potent inhibitors of glutathione S-transferase Mu expression by 't Hoen, Peter A C, Rosema, Bram-Sieben, Commandeur, Jan N M, Vermeulen, Nico P E, Manoharan, Muthiah, van Berkel, Theo J C, Biessen, Eric A L, Bijsterbosch, Martin K

“…Antisense oligodeoxynucleotides (AS-ODNs) are frequently used for the down-regulation of protein expression. Because the majority of potential antisense…”
Get full text

M38. PATIENT-PERSPECTIVE: NEED FOR CARE AFTER A FIRST PSYCHOSIS by Heijden-Hobus, Inge, van der Heijden-Hobus, Inge, Rosema, Bram-Sieben, Vorstman, Jacob, Kas, Martien, Begemann, Marieke, Kikkert, Martijn, Sommer, Iris

“…Abstract Background Only little is information is available about the needs and preferences regarding care and treatment of people who are going through a…”
Get full text

An ethics analysis of antipsychotic dose reduction and discontinuation: Principles for supporting recovery from psychosis by Allott, Kelly, Pert, Allie, Rattray, Audrey, Cooper, Ruth E, Winther Davy, Josefine, Grünwald, Lisa, Horowitz, Mark, Moncrieff, Joanna, Rosema, Bram-Sieben, Simmons, Magenta, Stainton, Alexandra, Stürup, Anne Emilie, Killackey, Eóin

“…To examine the evidence and practice of antipsychotic dose reduction from the lens of biomedical ethics (specifically principlism) to support evidence-based…”
Get full text

Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients by de Beer, Franciska, Koops, Sanne, Schoevers, Robert A., Veling, Wim, van Beveren, Nico, de Haan, Lieuwe, Boonstra, Nynke, Kikkert, Martijn, Begemann, Marieke J. H.

“…Clinical outcomes after a first-episode of psychosis (FEP) are heterogeneous. Many patient-related factors such as gender and comorbidity have been studied to…”
Get full text

Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium by Koops, Sanne, Allott, Kelly, de Haan, Lieuwe, Chen, Eric, Hui, Christy, Killackey, Eoin, Long, Maria, Moncrieff, Joanna, Sommer, Iris, Stürup, Anne Emilie, Wunderink, Lex, Begemann, Marieke

Get full text

Selection of effective antisense oligodeoxynucleotides with a green fluorescent protein‐based assay by ′t Hoen, Peter A. C., Rosema, Bram‐Sieben, Commandeur, Jan N. M., Vermeulen, Nico P. E., Manoharan, Muthiah, van Berkel, Theo J. C., Biessen, Eric A. L., Bijsterbosch, Martin K.

“…Antisense oligodeoxynucleotides (AS‐ODNs) are frequently used for the down‐regulation of protein expression. Because the majority of potential antisense…”
Get full text